Illumina (NasdaqGS:ILMN) expanded its Alliance for Genomic Discovery by adding Regeneron Genetics Center. The partners launched a large-scale program to pair whole genome sequences with proteomic data ...

Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.

Background Despite several studies suggesting a potential oligogenic risk model in amyotrophic lateral sclerosis (ALS), case–control statistical evidence implicating oligogenicity with disease risk or ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

We analyzed data from 306,796 UK Biobank participants. A weighted polygenic risk score (PRS) for Hcy was constructed and tested for associations with cardiovascular and neuroimaging phenotypes.

Gates, N.Y. (WHAM) — Rochester Regional Health is now offering a new genetic screening program and research tool, GenoWell, that shows how your DNA impacts participants' health. "This is the future of ...

ROCHESTER, N.Y. – Rochester Regional Health has launched a new genetic screening program, free of charge, to adults in our community. Almost anyone over the age of 18 is eligible to take part in the ...

The development of many psychiatric disorders, including depression, schizophrenia and bipolar disorder, is known to be in great part influenced by genetics. Past research has identified various genes ...

Abstract: Mathematics is filled with conjectures that involve infinite recursive structure, representing complex structures and underlying deep relationships. Discovering such conjectures is crucial ...

A bankruptcy judge’s signoff on 23andMe’s sale of genetic data exposes privacy law loopholes in a carefully structured deal and sets the stage for increased regulatory scrutiny. Judge Brian C. Walsh ...

A bankruptcy judge has approved the sale of the insolvent genetics firm 23andMe to a nonprofit run by one of the company's co-founders. The deal effectively avoids the controversial transfer of DNA ...